A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

Clinical trial NCT06246968 · RECRUITING

Trial details

NCT number: NCT06246968
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Breast Cancer Breast Cancer Stage IV Triple Negative Breast Cancer Triple Negative Breast Neoplasms Metastatic Triple-Negative Breast Carcinoma Locally Advanced Breast Cancer Locally Advanced Triple-Negative Breast Carcinoma

Start date: 2024-01-29
Primary completion: 2027-01-29
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.